Search by Drug Name or NDC

NDC 00078-0568-45 COARTEM 20; 120 mg/1; mg/1 Details

COARTEM 20; 120 mg/1; mg/1

COARTEM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is ARTEMETHER; LUMEFANTRINE.

MedlinePlus Drug Summary

The combination of artemether and lumefantrine is used to treat certain kinds of malaria infections (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death). Artemether and lumefantrine should not be used to prevent malaria. Artemether and lumefantrine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.

Related Packages: 00078-0568-45
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Artemether and Lumefantrine

Product Information

NDC	00078-0568
Product ID	0078-0568_d600e1b1-d1e7-44e9-98d7-4817fe2bf9e8
Associated GPIs	13990002030320
GCN Sequence Number	050710
GCN Sequence Number Description	artemether/lumefantrine TABLET 20MG-120MG ORAL
HIC3	W4A
HIC3 Description	ANTIMALARIAL DRUGS
GCN	17848
HICL Sequence Number	024021
HICL Sequence Number Description	ARTEMETHER/LUMEFANTRINE
Brand/Generic	Brand
Proprietary Name	COARTEM
Proprietary Name Suffix	n/a
Non-Proprietary Name	artemether and lumefantrine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	20; 120
Active Ingredient Units	mg/1; mg/1
Substance Name	ARTEMETHER; LUMEFANTRINE
Labeler Name	Novartis Pharmaceuticals Corporation
Pharmaceutical Class	Antimalarial [EPC], Antimalarial [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022268
Listing Certified Through	2024-12-31

Package

NDC 00078-0568-45 (00078056845)

Pricing Information	N/A
NDC Package Code	0078-0568-45
Billing NDC	00078056845
Package	24 TABLET in 1 BOTTLE (0078-0568-45)
Marketing Start Date	2009-04-07
NDC Exclude Flag	N